West Berlin, NJ (November 1, 2007)--EP MedSystems, Inc. (NASDAQ: EPMD), today reported its financial results for the third quarter ending September 30, 2007. The Company achieved record quarterly revenue of $5.3 million, representing a 41% increase over the $3.8 million reported for the same period in 2006, and a 23% sequential quarterly increase. Total revenue for the nine months ended September 30, 2007 was $13.2 million, an 18 % increase over the nine months ended September 30, 2006. The 2006 period included approximately $705,000 of nonrecurring sales to our Japanese distributor.
Software Release for the EP-WorkMate® Computerized Recording System EP MedSystems announces the latest release of software for the EP-WorkMate® Computerized Recording System. This new version of software features Frequency Mapping which is an advanced signal processing technique. This new feature creates a frequency spectrum for recorded electrogram signals using a signal processing algorithm known as the Fast Fourier Transform (FFT). The features of this new software module include: * Frequency spectrum conversion of all displayed signals on the Review screen * Dominant Frequency Mapping in the MAP window * Adjustable parameters for FFT filtering, resolution and range * Real-time FFT "Hunt" mode * 3D Frequency mapping on the EP-WorkMate with RPM system Reinhard Schmidt Epmd - Ep Medsystems Termination Since the company was founded in 1993, our products have been placed in hundreds of cath laboratories worldwide. Because we are completely dedicated to the field of cardiology we have no other products to dilute our attention or efforts. We are also publicly-held (NASDAQ: EPMD), so we have the resources to support operations, fund new product development, and promote long-term growth. Manufacturing Facility ISO 13485Certified